Open AccessDevelopment of Schamberg's disease after SARS‐CoV ‐2 vaccination
Author(s) -
Morimoto Hiroki,
Ogura Yasuaki,
Otsuka Masaki,
Hayano Satoshi,
Tokura Yoshiki
Publication year - 2022
Publication title -
journal of cutaneous immunology and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.127
H-Index - 1
ISSN - 2574-4593
DOI - 10.1002/cia2.12247
Subject(s) - vaccination , medicine , buttocks , purpura (gastropod) , disease , population , immunology , pathology , surgery , biology , ecology , environmental health
Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 weeks. No recurrence was observed thereafter. It is suggested that the vaccination triggered the development of the eruption, which was not merely coincidental. SARS‐CoV‐2 vaccination may stimulate a certain population of T cells, resulting in the development of pigmented purpuric dermatoses.